The application segmentation focuses on the clinical contexts in which disposable bone marrow transplantation needles are employed, namely allogeneic transplantation, autologous transplantation, and syngeneic transplantation. Allogeneic transplantation, involving donor‑derived marrow, requires higher needle reliability and sterility standards, driving the largest share of the market at an estimated 45% of total sales; this segment benefits from the expanding global donor registries and rising incidence of hematologic malignancies. Autologous transplantation, where patients receive their own harvested marrow, accounts for roughly 35% of market volume; its growth is linked to increasing use of high‑dose chemotherapy protocols and the need for cost‑effective disposable solutions. Syngeneic transplantation, the least common application involving genetically identical donors (e.g., identical twins), contributes about 20% of market revenue, reflecting its limited but specialized usage in rare clinical scenarios. The Disposable Bone Marrow Transplantation Needles segmentation by application thus maps directly onto procedural demand patterns and informs strategic positioning across the market.